Northern Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $665K | Buy |
5,204
+2,314
| +80% | +$289K | ﹤0.01% | 3499 |
|
|
2025
Q4 | $352K | Sell |
2,890
-4,139
| -59% | -$475K | ﹤0.01% | 3780 |
|
|
2025
Q3 | $704K | Sell |
7,029
-3,644
| -34% | -$328K | ﹤0.01% | 3536 |
|
|
2025
Q2 | $885K | Sell |
10,673
-4,502
| -30% | -$359K | ﹤0.01% | 3449 |
|
|
2025
Q1 | $1.23M | Buy |
15,175
+1,898
| +14% | +$170K | ﹤0.01% | 3189 |
|
|
2024
Q4 | $1.2M | Sell |
13,277
-16,732
| -56% | -$1.62M | ﹤0.01% | 3310 |
|
|
2024
Q3 | $2.96M | Buy |
30,009
+4,568
| +18% | +$449K | ﹤0.01% | 2761 |
|
|
2024
Q2 | $2.36M | Buy |
25,441
+274
| +1% | +$24.6K | ﹤0.01% | 2813 |
|
|
2024
Q1 | $2.39M | Sell |
25,167
-1,368
| -5% | -$127K | ﹤0.01% | 2867 |
|
|
2023
Q4 | $2.37M | Buy |
26,535
+4,169
| +19% | +$310K | ﹤0.01% | 2901 |
|
|
2023
Q3 | $1.63M | Sell |
22,366
-811
| -3% | -$64.8K | ﹤0.01% | 3049 |
|
|
2023
Q2 | $1.93M | Sell |
23,177
-1,394
| -6% | -$117K | ﹤0.01% | 3027 |
|
|
2023
Q1 | $1.87M | Buy |
24,571
+1,945
| +9% | +$161K | ﹤0.01% | 2970 |
|
|
2022
Q4 | $1.88M | Sell |
22,626
-450
| -2% | -$36.4K | ﹤0.01% | 3034 |
|
|
2022
Q3 | $1.83M | Buy |
23,076
+4,413
| +24% | +$372K | ﹤0.01% | 3052 |
|
|
2022
Q2 | $1.39M | Buy |
18,663
+1,810
| +11% | +$136K | ﹤0.01% | 3238 |
|
|
2022
Q1 | $1.51M | Buy |
16,853
+8,242
| +96% | +$761K | ﹤0.01% | 3240 |
|
|
2021
Q4 | $964K | Sell |
8,611
-3,602
| -29% | -$434K | ﹤0.01% | 3551 |
|
|
2021
Q3 | $1.53M | Buy |
12,213
+61
| +0.5% | +$7.86K | ﹤0.01% | 3400 |
|
|
2021
Q2 | $1.65M | Buy |
12,152
+9,670
| +390% | +$1.27M | ﹤0.01% | 3413 |
|
|
2021
Q1 | $337K | Buy |
+2,482
| New | +$372K | ﹤0.01% | 3942 |
|
|
2020
Q3 | – | Sell |
-251,412
| Closed | -$28.1M | – | 4326 |
|
|
2020
Q2 | $28.1M | Buy |
+251,412
| New | +$24.8M | 0.01% | 1337 |
|
|
2019
Q3 | – | Sell |
-3,149
| Closed | -$276K | – | 4297 |
|
|
2019
Q2 | $276K | Sell |
3,149
-600
| -16% | -$51.2K | ﹤0.01% | 3724 |
|
|
2019
Q1 | $339K | Sell |
3,749
-347
| -8% | -$29.5K | ﹤0.01% | 3638 |
|
|
2018
Q4 | $294K | Sell |
4,096
-739
| -15% | -$59.5K | ﹤0.01% | 3681 |
|
|
2018
Q3 | $464K | Sell |
4,835
-100
| -2% | -$9.7K | ﹤0.01% | 3648 |
|
|
2018
Q2 | $470K | Buy |
4,935
+1,789
| +57% | +$164K | ﹤0.01% | 3614 |
|
|
2018
Q1 | $276K | Sell |
3,146
-34
| -1% | -$3.1K | ﹤0.01% | 3735 |
|
|
2017
Q4 | $270K | Sell |
3,180
-2,650
| -45% | -$222K | ﹤0.01% | 3718 |
|
|
2017
Q3 | $505K | Buy |
5,830
+769
| +15% | +$61.7K | ﹤0.01% | 3569 |
|
|
2017
Q2 | $391K | Buy |
5,061
+2,050
| +68% | +$145K | ﹤0.01% | 3630 |
|
|
2017
Q1 | $209K | Buy |
+3,011
| New | +$202K | ﹤0.01% | 3781 |
|
|
2016
Q2 | – | Sell |
-20,627
| Closed | -$1.07M | – | 4278 |
|
|
2016
Q1 | $1.07M | Hold |
20,627
| – | – | ﹤0.01% | 3235 |
|
|
2015
Q4 | $1.45M | Buy |
20,627
+245
| +1% | +$16.7K | ﹤0.01% | 3191 |
|
|
2015
Q3 | $1.27M | Sell |
20,382
-579
| -3% | -$45.6K | ﹤0.01% | 3241 |
|
|
2015
Q2 | $1.76M | Sell |
20,961
-2,154
| -9% | -$168K | ﹤0.01% | 3124 |
|
|
2015
Q1 | $1.74M | Sell |
23,115
-5,430
| -19% | -$379K | ﹤0.01% | 3204 |
|
|
2014
Q4 | $1.77M | Buy |
28,545
+5,400
| +23% | +$308K | ﹤0.01% | 3176 |
|
|
2014
Q3 | $1.2M | Sell |
23,145
-600
| -3% | -$30.6K | ﹤0.01% | 3354 |
|
|
2014
Q2 | $1.22M | Sell |
23,745
-2,403
| -9% | -$108K | ﹤0.01% | 3324 |
|
|
2014
Q1 | $1.24M | Buy |
26,148
+2,460
| +10% | +$126K | ﹤0.01% | 3338 |
|
|
2013
Q4 | $1.03M | Sell |
23,688
-21,087
| -47% | -$873K | ﹤0.01% | 3371 |
|
|
2013
Q3 | $1.93M | Sell |
44,775
-9,480
| -17% | -$384K | ﹤0.01% | 3115 |
|
|
2013
Q2 | $1.89M | Buy |
+54,255
| New | +$1.91M | ﹤0.01% | 3022 |
|
Other funds holding XBI
Northern Trust's XBI Position: Q1 2026 in Review
Northern Trust increased its State Street SPDR S&P Biotech ETF (XBI) stake by 80% in Q1 2026, buying an estimated $289K and bringing the position to 5,204 shares worth $665K. The position accounts for ﹤0.01% of the portfolio, ranked #3499.
Northern Trust first reported a position in XBI in Q2 2013 and has held it in 44 quarters since. The position peaked at $28.1M in Q2 2020. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Northern Trust held 5,204 shares of State Street SPDR S&P Biotech ETF worth $665K as of Q1 2026.
- Northern Trust bought 2,314 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $289K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3499 holding.
- Northern Trust first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 44 quarters since.
- Northern Trust's State Street SPDR S&P Biotech ETF position peaked at $28.1M in Q2 2020.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.